Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Buy
63,907
+7,725
+14% +$1.11M 0.74% 26
2026
Q1
$7.1M Sell
56,182
-100
-0.2% -$14.1K 0.54% 28
2025
Q4
$7.61M Sell
56,282
-280,115
-83% -$37.5M 0.6% 23
2025
Q3
$41.6M Sell
336,397
-268,401
-44% -$29.5M 3.39% 16
2025
Q2
$59.7M Sell
604,798
-440,568
-42% -$36M 4.81% 12
2025
Q1
$68.6M Buy
+1,045,366
New +$71.3M 6.04% 1

Other funds holding APH

M.D. Sass LLC's APH Position: Q2 2026 in Review

M.D. Sass LLC increased its Amphenol (APH) stake by 14% in Q2 2026, buying an estimated $1.11M and bringing the position to 63,907 shares worth $11.3M. The position accounts for 0.74% of the portfolio, ranked #26.

M.D. Sass LLC first reported a position in APH in Q1 2025 and has held it in 6 quarters since. The position peaked at $68.6M in Q1 2025. 2,314 funds tracked by Wall St. Rank hold APH as of Q2 2026.

  • M.D. Sass LLC held 63,907 shares of Amphenol worth $11.3M as of Q2 2026.
  • M.D. Sass LLC bought 7,725 Amphenol shares in Q2 2026, an estimated $1.11M.
  • Amphenol made up 0.74% of M.D. Sass LLC's portfolio in Q2 2026, its #26 holding.
  • M.D. Sass LLC first reported a position in Amphenol in Q1 2025 and has held it in 6 quarters since.
  • M.D. Sass LLC's Amphenol position peaked at $68.6M in Q1 2025.
  • 2,314 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on M.D. Sass LLC's 13F filing for Q2 2026, filed 7 Aug 2026.